Raymond James analyst Jayson Bedford maintains Johnson & Johnson (NYSE:JNJ) with a Outperform and lowers the price target from $196 to $192.
Here’s How Much You Would Have Made Owning Prologis Stock In The Last 10 Years
Prologis (NYSE:PLD) has outperformed the market over the past 10 years by 1.97% on an annualized basis producing…